PLYMOUTH MEETING, Pa. (AP) _ Inovio Pharmaceuticals Inc. (INO) on Tuesday reported a third-quarter loss of $60.2 million, after reporting a profit in the same period a year earlier.

The Plymouth Meeting, Pennsylvania-based company said it had a loss of 29 cents per share.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share.

The drugmaker posted revenue of $291,698 in the period. Its adjusted revenue was $292,000, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $190,000.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INO at https://www.zacks.com/ap/INO

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News